No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
AEON Biopharma's Strategic Progress and Financial Turnaround
Express News | AEON Biopharma Inc - Jost Fischer Appointed Interim CEO
Express News | AEON Biopharma Inc - Marc Forth Steps Down as President and CEO Effective April 4, 2025
Press Release: AEON Biopharma Announces CEO Transition
AEON Biopharma | 10-K: FY2024 Annual Report
AEON Biopharma | 8-K: AEON Biopharma Reports Fourth Quarter 2024 and Full Year Financial Results and Provides Corporate Update